Membrane type I metalloproteinase (mt1-mmp) as a target in cancer : a study of two inhibitors.
Several diseases, including cancer, have been associated with high membrane type-1 matrix metalloproteinase (MT1-MMP) expression levels. MT1-MMP together with a non-membrane-bound, soluble MMP, MMP-2, also associated with many other biological functions, have been implicated in breast cancer progres...
Main Author: | Bohnen, Daniel. |
---|---|
Other Authors: | Elliott, Edith. |
Language: | en_ZA |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10413/10552 |
Similar Items
-
Membrane type-1 matrix metalloproteinase (MT1-MMP) as a target in cancer therapy.
by: Crouch, Candice Julie.
Published: (2014) -
Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer?
by: Suada Kuskunović-Vlahovljak, et al.
Published: (2017-12-01) -
Role of MMP2, MMP3 and MMP9 in the development of breast cancer brain and lung metastasis in a syngeneic rat model
by: Mendes, Odete Rodrigues
Published: (2005) -
Matrix metalloproteinase9 as the protein target in anti-breast cancer drug discovery: an approach by targeting hemopexin domain
by: Christophorus Fideluno Adhipandito, et al.
Published: (2019-09-01) -
Differential membrane-type matrix metalloproteinase expression in phenotypically defined breast cancer cell lines: Comparison of MT-MMP expression in environmentally-challenged 2D monolayer cultures and 3D multicellular tumour spheroids
by: Kashtl, Ghasaq J.
Published: (2019)